VYDURA Sampling Terms and Conditions
|
|
VYDURA Sampling Terms and Conditions |
|
Vydura Prescribing information can be found here, and Adverse Event reporting can be found at the end of this document. This document is intended to be read electronically.
Pfizer Limited (“Pfizer”) wishes to confirm that your request has been accepted to be a part of the sampling programme (“Programme”) in respect of Vydura (rimegepant) (“Product”). The Programme shall be subject to the terms and conditions below. By ticking the box below, you confirm you are a qualified healthcare professional who is lawfully allowed to prescribe the Product and that you agree to the terms and conditions contained herein.
-
On the link provided by Pfizer to you, you shall have the ability to order up to 4 samples of the smallest pack of Product available. For the avoidance of doubt, you will only receive a maximum of four of the smallest pack of Product within a 12-month period from the date of your first request. Samples of a particular medicine may be provided to you for no longer than two years after you first requested samples of it.
-
Pfizer will send the Product to a hospital, or GP practice requested by you that has an Alliance Healthcare Account. The Product will be delivered via Alliance Healthcare to the on- site pharmacy or dispensary if there is one on site, alternatively for GP practices without a dispensary it can be delivered to the reception where it must be kept securely. It is your responsibility to follow up with the Pharmacist, dispenser or receptionist at your requested Hospital or GP practice and collect the Product.
-
You should only request Vydura (rimegepant) sample(s) if your institution allows for this under a sampling policy or part of a wider ‘Safer Use of Medicines’ policy or similar.
-
Pfizer shall be entitled to suspend access to the Programme at any time by giving written notice. Pfizer shall further have the right to the end the Programme at any time by giving you 60 days’ written notice.
-
If you intend to prescribe for patients, the medicine must be used within the terms of its Marketing Authorisation and must not be inconsistent with the particulars listed in its summary of product characteristics.
-
The Product must only be used for providing a patient with a free sample and must not be resold or otherwise used outside the Programme.
-
Pfizer shall not be liable for lost or damaged Product.
-
You will comply with all adverse event reporting requirements in relation to the Product in accordance with normal medical practice and MHRA reporting requirements. Adverse event reports can be made using the Pfizer's Adverse Event Reporting Portal (pfizersafetyreporting.com)
-
Each party shall comply with all applicable laws. For the avoidance of any doubt, this engagement is a stand-alone arrangement which is not dependent on or related to any past, present, or future commercial relationship between Pfizer and you or any business or other decision(s) that you have made or may make relating to Pfizer or any of its products. Pfizer may not incentivise or reward healthcare professionals for their past, present, or future use or support of Pfizer medicines or to influence the outcome of any clinical trial(s) or for any other improper purpose. Pfizer does not require or expect you to exercise your influence (if any) in its favour. If you have concerns about this arrangement or the way it is established or run, please report these to Pfizer’s Legal team (which can be contacted through Pfizer’s Walton Oaks switchboard or address).
-
Neither Pfizer nor you will through the operation of this agreement seek to improperly influence prescribing behaviour, the outcome of clinical trials or any healthcare professional or other government official with the intent to obtain or retain business for Pfizer or for any other improper purpose. If either party breaches this clause 9, the other party shall be entitled to end this agreement immediately, without prejudice to any rights that may have accrued to the terminating party before termination.
-
You will not, without Pfizer's prior written consent, disclose to or use to the advantage (direct or indirect) of any company, firm, body or person(s) other than Pfizer, any information acquired in the course of the Programme concerning these terms and conditions, Pfizer's personnel, research activities, products, other business operations or any other information which would be regarded as confidential by a reasonable business person (together “Confidential Information”). At Pfizer's request, and in any event on termination or expiry of these terms and conditions, you shall (as directed by Pfizer) return or destroy all documents and other records containing or relating to Confidential Information and certify to Pfizer that such full return or destruction has been affected. The confidentiality obligations imposed by these terms and conditions will remain binding for a period of five (5) years from the date of expiry or termination of these terms and conditions.
-
You shall comply with your obligations under the Data Protection Laws. For the purpose of this clause, “Data Protection Laws” means for so long as European regulations are directly applicable in the United Kingdom, (i) the General Data Protection Regulation (Regulation (EU) 2016/679 of the European Parliament and the Council of 27 April 2016) and any consequential national data protection legislation; (ii) the UK Data Protection Act 2018; and (iii) any guidance and/or codes of practice issued by the UK Information Commissioner’s Office or other relevant supervisory authority, including without limitation (for so long as European regulators have jurisdiction over the United Kingdom) the European Data Protection Board, in each case as amended, supplemented or replaced from time to time.
Specific purpose and retention. Pfizer shall process professional personal data relating to the individuals who legally represent or otherwise work for you (the “Contractual Personal Data”) to manage these terms and conditions, comply with any applicable regulatory requirements and meet Pfizer’s legitimate interests in maintaining its business (e.g., to conduct background checks to ensure Pfizer is not precluded from working with you or to ensure the security of our IT systems). The Contractual Personal Data shall include the relevant individual’s identity, business contact and corporate details, electronic identification data if accessing Pfizer’s technology and details of the contractual relationship, including training and banking details if applicable. The Contractual Personal Data shall be kept as long as the contractual rights and duties arising from these terms and conditions and applicable regulatory rights and duties could be enforced by or against Pfizer.
International transfers. Only for the above-mentioned purposes, Pfizer may store the Contractual Personal Data in centralized databases and disclose them to its Affiliates in other countries (https://selfservehosteu.pfizer.com/legal-entities), to its vendors and to regulatory authorities, in all cases throughout the world (including the US). The US, as any other non-EU country as a general rule, does not have personal data laws similar to the European ones. The full list of non-EEA countries with data protection standards similar to the EEA ones is available here at http://ec.europa.eu/justice/data-protection/internationaltransfers/adequacy/index_en.htm. The Pfizer group of companies has put in place appropriate safeguards both within its group and with non-EEA/Swiss vendors (such as contracts approved by the EU authorities available at http://ec.europa.eu/justice/data-protection/internationaltransfers/transfer/index_en.htm; as may be updated by the European Commission from time to time or substantially equivalent guarantees under EEA/Swiss data protection regulations). Further information on these safeguards may be found by contacting the DPO, as indicated below.
Data protection requests. Data subjects shall communicate any requests in relation to this clause to Pfizer, as indicated below and as may be updated from time to time on reasonable prior written notice.Pfizer
DPO
DPO.Pfizer.com
Data protection rights (e.g., access, rectification, erasure, restriction, portability, and objection)
[to be completed by the data subject submitting a request to Pfizer’s DPO]
The data subject may lodge a complaint with the supervisory data protection authority of his/her country if he/she disagrees with the specific response to a data protection request.
-
The failure of a party to enforce any provision of these terms and conditions shall not constitute a waiver nor affect its right to enforce such and every other provision.
-
Pfizer may update these terms and conditions from time to time.
These terms and conditions shall be governed by and construed in accordance with English law.
